|
|
 |
Search published articles |
 |
|
Showing 4 results for Moradi F
Akbarzadeh M (msc), Moradi F (msc), Dabbaghmanesh Mh (md), Jafari P (phd), Parsanezhad Me (md), Volume 12, Issue 4 (12-2010)
Abstract
Background and Objective: Polycystic ovarian syndrome (PCOS) is one of the most prevalent (6-10%) endocrine glands disorders among child - bearing women. In addition to the patients, their first degree relatives are exposed to some risk factors such as abnormal lipoproteins. Due to high prevalence PCOS among women and the role of genetic factors in this abnormality, it is necessary to recognize high risk people particularly among first degree relative. Therefore this study was conducted to determine the level of serum lipoproteins in first degree relatives of patients with PCOS. Materials and Methods: This case control study was done on 107 individuals of the first degree relatives of PCOS patients as cases and 107 normal individuals of the first degree of non-PCOS as controls in Shiraz, Iran during 2009. Participants completed a test assessing demographics and blood sample were taken from all participants in order to assay serum lipoproteins including total cholesterol, LDL, HDL and triglyceride. Data was analyzed by means of independent t-test and Fisher's exact test as well as Chi-Square. Results: The means±SD of total cholesterol, HDLc and triglyceride in cases was 191±31.64, 167±4.06 and 191±31.64 mg/dl, respectively. The means±SD of total cholesterol, LDLc and triglyceride in controls was 158.25±18.25, 123±21.33 and 120.42±17.11 mg/dl, respectively. Serum level differences of LDL and triglyceride in cases and controls were significant (P<0.05). The means±SD of HDLc in cases and controls was 40.06±6.95 and 45.9±6.7 mg/dl, respectively (P<0.05). Conclusion: This study showed that the serum level of lipoproteins in the first degree relatives of PCOS patients is significant higher than non-PCOS.
Akbarzadeh M (msc), Moradi F (msc), Dabbaghmanesh Mh (md), Jafari P (phd), Volume 14, Issue 2 (6-2012)
Abstract
Background and Objective: There is a genetic background for polycystic ovary syndrome (PCOS). Due to increase metabolic disorders, lipoproteins, impaired glucose tolerance, and hypertension in PCOS patients, this study was done to determine the cardiovascular risk factors in first relative member of patients with polycystic ovarian syndrom in Shiraz, Iran. Materials and Methods: This case - control study was carried out on 107 parents and siblings of women with PCOS as cases and 107 non-PCOS parents and siblings of women as controls in Shiraz, Iran during 2007-08. Demographic characteristic, BMI, obesity and blood pressure were recorded for all subjects. Serum lipoproteins including total cholestrol, triglyceride, LDL, HDL and fasting blood sugar were measured in cases and controls. Data were analyzed using SPSS-16.5, independent t-test, Chi-Square and Kappa tests. Results: 35.3%, 26.5%, 11.76% and 5.8% of fatheres in cases were considered as overweight class I, class II, class III of obesity, respectively when compared to controls. This differecne was significant (P<0.05). Waist –hip ratio in mothers in cases (25.6%) and controls (17.9%) were higher than 0.85. Waist –hip ratio among the sisters in case and control groups were 23.5% and 17.6%, respectively (P<0.05). Hypertension was observed in 12.2% of cases and 3.7% of controls. This difference was not significant. High level of triglyceride were determined in 14.94% of cases and 6.5% of controls. A significant correlation was found between BMI and diabete II in case and control groups (P<0.05). Disorder in glucose tolerance test (GTT) in case and control goups were 19.62% and 7.47%, respectively (P<0.05). The obesity was found in 18.7%, 6.54% in cases and controls with disorder in GTT (P<0.05). Conclusion: This study showed that obesity, central obesity, high level of serum lipoproteins and hypertension among first relative member of patients with PCOS are significantly higher than the controls.
Kouhi F, Moradi F, Absazadegan M, Volume 16, Issue 1 (3-2014)
Abstract
Background and Objective: Previous studies have reported inconsistent findings about the effect of endurance training on level of interleukin-18 (IL-18) and high-sensitivity C-reactive protein (hsCRP) in obese individuals. This study was performed to determine the effect of resistance training on serum level of IL-18 and hsCRP in obese men. Materials and Methods: In this clinical trial, eighteen obese men were randomly divided into training and control groups. After 12-hours fasting, height, weight, body mass index, body fat percent, serum level of IL-18 and hsCRP were assessed before and after training period. Resistance training protocol consisted of twelve weeks training, 3 sessions training per week, each session for 60 minutes. Results: Mean±SD of IL-18 were 323.34±46.57 pg/ml and 239.43±53.75 pg/ml in training and control groups, respectively. Mean±SD of hsCRP was 3.83±3.65 µg/ml and 3.03±2.98 µg/ml in training and control groups, respectively. This difference was not significant. Conclusion: Performing resistance training for twelve weeks did not significantly reduce IL-18 and hsCRP in obese men.
Moradi F, Volume 17, Issue 4 (12-2015)
Abstract
Background and Objective: A few data is available about effect of exercise training on level of resistin and novel insulin resistance indices in underweight inactive men. This study was performed to determine the effect of a period of resistance training on serum level of resistin and insulin resistance indices in underweight inactive men. Methods: In this clinical trial study, nineteen underweight inactive men were randomly divided into resistance training (n=9, 20.9±3.6 yr) and controls (n=10, 21.4±2.7 yr). Resistance training protocol consisted of twelve weeks weight training, 3 sessions training per week, each session for 60 minutes. General characteristics of subjects, serum concentration of resistin, and indices adiponectin-resistin (AR), homeostasis model assessment - adiponectin ratio (HOMA-AD) and insulin resistance (IRAR) were assessed before and after the training. Results: HOMA-AD and IRAR were reduced in resistance training group compare to controls, while serum resistin and AR did not significant reduce. Pretest-posttest difference means of HOMA-AD and IRAR were different between resistance training and control groups, while no significant differences were observed in the case of serum resistin concentration and AR. These parameters were not significant in the control group. Conclusion: Resistance training is associated with improved insulin resistance (decrease of HOMA-AD and IRAR indices), while did not change resistin level in underweight inactive men.
|
|